KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 113 filers reported holding KALVISTA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $12,241,000 | -21.3% | 830,472 | -29.3% | 0.27% | -16.0% |
| Q4 2021 | $15,547,000 | -58.8% | 1,175,131 | -45.7% | 0.33% | -55.8% |
| Q3 2021 | $37,754,000 | -27.2% | 2,163,554 | 0.0% | 0.74% | -20.0% |
| Q2 2021 | $51,839,000 | +97.8% | 2,163,554 | +112.1% | 0.92% | +67.2% |
| Q1 2021 | $26,204,000 | +153.6% | 1,020,005 | +14.5% | 0.55% | +30.9% |
| Q3 2019 | $10,332,000 | -61.7% | 890,668 | -26.9% | 0.42% | -56.6% |
| Q2 2019 | $26,971,000 | +45.0% | 1,217,668 | +87.3% | 0.97% | +35.9% |
| Q1 2019 | $18,603,000 | +44.9% | 650,000 | 0.0% | 0.71% | +38.7% |
| Q4 2018 | $12,838,000 | -10.7% | 650,000 | 0.0% | 0.51% | -0.2% |
| Q3 2018 | $14,372,000 | – | 650,000 | – | 0.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,719,576 | $25,679,000 | 12.37% |
| Vivo Capital, LLC | 1,618,296 | $30,731,000 | 1.37% |
| Opaleye Management Inc. | 470,203 | $8,929,000 | 1.17% |
| INTERWEST VENTURE MANAGEMENT CO | 388,766 | $7,383,000 | 0.92% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 177,433 | $3,369,000 | 0.92% |
| Ikarian Capital, LLC | 1,063,961 | $20,204,000 | 0.89% |
| Ghost Tree Capital, LLC | 200,000 | $3,798,000 | 0.85% |
| Logos Global Management LP | 490,000 | $9,305,000 | 0.80% |
| Eventide Asset Management | 1,680,000 | $31,903,000 | 0.49% |
| Affinity Asset Advisors, LLC | 45,000 | $855,000 | 0.45% |